Psychiatric Quarterly

, Volume 66, Issue 1, pp 87-95

First online:

Bromocriptine and psychosis: A literature review

  • Alan BoydAffiliated withTulane Medical Center, Department of Psychiatry and Neurology, Tulane University

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access


Bromocriptine is an ergot-derived dopamine agonist. Its current uses include the treatment of Parkinson's disease, postpartum ablaction, prolactionmas, acromegaly, and amenorrhea and galactorrhea secondary to neuroleptic use. It is often reported to produce psychiatric side effects such as confusion, hallucinations, and delusions. The literature is reviewed and supports a strong anecdotal relationship between bromocriptine use and psychosis.